At Investor Conferences

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

News > All

Total search results: 1345 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Grifols S.A.. (11/13/19). "Press Release: Grifols and Shanghai RAAS Obtain Authorization for Their Strategic Alliance in China". Barcelona. 2019-11-13
Vaximm AG. (11/12/19). "Press Release: NEC and Vaximm Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines". Tokyo, Basel & Mannheim. 2019-11-12
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development". 2019-11-06
Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. 2019-10-31
BeiGene, Ltd.. (10/31/19). "Press Release: BeiGene Announces Global Strategic Oncology Collaboration with Amgen". Cambridge, MA & Beijing. 2019-10-31
Phathom Pharmaceuticals, Inc.. (10/29/19). "Press Release: Phathom Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Buffalo Grove, IL. 2019-10-29
Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. 2019-10-29
BiomX Ltd.. (10/28/19). "Press Release: Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-28
AstraZeneca plc. (10/24/19). "Press Release: Year-to-Date and Q3 2019 Results". 2019-10-24
Phathom Pharmaceuticals, Inc.. (10/24/19). "Press Release: Phathom Pharmaceuticals Announces Pricing of Initial Public Offering". Buffalo Grove, IL. 2019-10-24
Pepticom. (10/24/19). "Press Release: Pepticom Raises $5 Million in Series A Funding. Jerusalem-based Startup Uses AI to Accelerate Drug Discovery". Jerusalem. 2019-10-24
BiomX Ltd.. (10/23/19). "Press Release: Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-23
Qpex Biopharma, Inc.. (10/22/19). "Press Release: Qpex Biopharma and Brii Biosciences Enter into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-resistant Infections in China". San Diego, CA. 2019-10-22
Verseau Therapeutics, Inc.. (10/21/19). "Press Release: Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board". Bedford, MA. 2019-10-21
Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA. 2019-10-21
Merck KGaA. (10/18/19). "Press Release: Merck Launches Seed Fund for Startups in China". Darmstadt. 2019-10-18
Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. 2019-10-16
GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. 2019-10-16
BiomX Ltd.. (10/14/19). "Press Release: Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-14
MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. 2019-10-14
Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. 2019-10-10
Insilico Medicine. (10/9/19). "Press Release: CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million". Hong Kong & Nanjing. 2019-10-09
Bluebee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk. 2019-10-09
Bayer AG. (10/8/19). "Press Release: Bayer and RIKEN Innovation Establish Partnership in Drug Discovery". Osaka & Tokyo. 2019-10-08
Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto. 2019-10-08
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. 2019-10-07
Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA. 2019-10-04
Agilent Technologies Inc.. (10/2/19). "Press Release: Agilent Receives Approval for First PD-L1 Companion Diagnostic in China". Santa Clara, CA. 2019-10-02
Numab Therapeutics AG. (10/1/19). "Press Release: Numab and Eisai Enter into a Global Research and Option Agreement to Discover and Develop Multi-specific Antibody Immunotherapies for Cancer". Tokyo & Zurich. 2019-10-01
Phathom Pharmaceuticals, Inc.. (9/27/19). "Press Release: Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments". Buffalo Grove, IL. 2019-09-27
Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg. 2019-09-24
H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan". 2019-09-20
Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. 2019-09-20
Agilent Technologies Inc.. (9/19/19). "Press Release: Agilent Presents Thought Leader Award to Professor Hualiang Jiang". Santa Clara, CA. 2019-09-19
BenevolentAI Ltd.. (9/17/19). "Press Release: BenevolentAI Announces $90 Million Investment from Temasek". London. 2019-09-17
Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris. 2019-09-12
Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA. 2019-09-11
Genenta Science S.r.l.. (9/11/19). "Press Release: Genenta Science Announces 13.2 Million in a New Round of Financing, Hits a Total above 30 Million since Inception. Two Clinical Trials Ongoing.". Milano & New York, NY. 2019-09-11
Atomwise, Inc.. (9/11/19). "Press Release: Atomwise Announces Largest China-US Collaboration for AI Drug Discovery". San Francisco, CA. 2019-09-11
Amra Medical AB. (9/10/19). "Press Release: Amra Announces Strategic Partnership with Japanese Leading Imaging CRO, Micron, Inc., to Support Clinical Trials in Japan". Linköping. 2019-09-10
Insilico Medicine. (9/10/19). "Press Release: Insilico Medicine Secures $37m in Series B Funding Led by Qiming Venture Partners". Hong Kong. 2019-09-10
Evonik Industries AG. (9/5/19). "Press Release: Evonik Invests in Chinese 3D-printing Start-up Making Medical Implants". Essen & Shanghai. 2019-09-05
Boehringer Ingelheim. (9/4/19). "Press Release: Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound". Ingelheim & Mumbai. 2019-09-04
Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen. 2019-08-28
Agilent Technologies Inc.. (8/28/19). "Press Release: Agilent Presents Thought Leader Award to Professor Hyun Joo An". Santa Clara, CA. 2019-08-28
HiFiBio Therapeutics. (8/28/19). "Press Release: HiFiBio Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders". Cambridge, MA, Shanghai & Paris. 2019-08-28
Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire. 2019-08-27
Atonarp Inc.. (8/26/19). "Press Release: Atonarp Inc. Announces $33 Million Series C Funding Round Completion". Tokyo. 2019-08-26
GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London. 2019-08-23
AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease". 2019-08-22
Finch Therapeutics Group, Inc.. (8/22/19). "Press Release: Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas". Somerville, MA. 2019-08-22
Inex Innovate. (8/21/19). "Press Release: Inex and Nova Satra Announce Merger to Become Inex Innovate, Asia’s First Femtech Innovations Group". Singapore. 2019-08-21
GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London. 2019-08-21
Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. 2019-08-21
Genomenon, Inc.. (8/20/19). "Press Release: Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market". Ann Arbor, MI. 2019-08-20
Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund. 2019-08-20
H. Lundbeck A/S. (8/14/19). "Press Release: Lundbeck Appoints New EVP, People & Communication". Valby. 2019-08-14
NRGene. (8/12/19). "Press Release: NRGene Announces Management and Business Updates". Ness Ziona & San Diego, CA. 2019-08-12
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim Opens Health Management Centre in China". Shanghai. 2019-08-12
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". 2019-08-08
Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. 2019-08-05
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. 2019-08-05
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". 2019-07-31
Qiagen N.V.. (7/24/19). "Press Release: Qiagen Reports Results for Second Quarter of 2019 – Updates Full-year 2019 Outlook Due to Decision to Restructure China NGS Partnership". Venlo. 2019-07-24
Frequency Therapeutics, Inc.. (7/23/19). "Press Release: Frequency Therapeutics Completes $62 Million Series C Financing". Woburn, MA. 2019-07-23
Cytena GmbH. (7/23/19). "Press Release: Cytena Founds Subsidiary in Taiwan". Freiburg. 2019-07-23
Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel. 2019-07-19
Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam. 2019-07-18
BiomX Ltd.. (7/17/19). "Press Release: Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. 2019-07-17
Frequency Therapeutics, Inc.. (7/17/19). "Press Release: Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss". Tokyo & Woburn, MA. 2019-07-17
Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. 2019-07-16
BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. 2019-07-09
PhoreMost Ltd.. (7/8/19). "Press Release: PhoreMost and inStem Enter Structural Biology Alliance". Cambridge. 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
Evotec SE. (7/8/19). "Press Release: Evotec and Venture Capital Consortium Form Breakpoint Therapeutics GmbH". Hamburg. 2019-07-08
[iito] Business Intelligence. (7/7/19). "THIS IS A DEMO VERSION! NOT INTENDED FOR PUBLIC USE! There is no official launch of Life-Sciences-Asia.com planned any time soon.". 2019-07-07
ACT Genomics Holdings Co., Ltd.. (7/5/19). "Press Release: ACT Genomics Opens Third Laboratory in Asia at Hong Kong Science Park". Hong Kong. 2019-07-05
Citryll B.V.. (7/3/19). "Press Release: Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody". Oss. 2019-07-03
GlaxoSmithKline plc. (7/3/19). "Press Release: ViiV Healthcare Receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection". London. 2019-07-03
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
Photocure ASA. (7/1/19). "Press Release: Photocure and Asieris Enter into a Global Licensing Deal for Cevira with up to USD 250 Million in Milestones and Double-digit Royalties". Oslo. 2019-07-01
Boehringer Ingelheim. (7/1/19). "Press Release: Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline with New First-in-Class Compound from Yuhan Corporation". Ingelheim & Seoul. 2019-07-01
Bayer AG. (7/1/19). "Press Release: Century Therapeutics Launches with USD 250M Financing for induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform". Leverkusen, Philadelphia, PA & Tokyo. 2019-07-01
Illumina, Inc.. (6/25/19). "News: Chinese Collaboration to Develop Cancer Tests on Illumina System. AnchorDx to Focus on Early Cancer Detection and Clinical Management Panels". 2019-06-25
Gilead Sciences, Inc.. (6/24/19). "Press Release: Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies". Foster City, CA & Kobe. 2019-06-24
Genfit S.A.. (6/24/19). "Press Release: Genfit and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China". Lille & Cambridge, MA. 2019-06-24
AB Sciex (d/b/a Sciex). (6/21/19). "Press Release: Sciex Announces Co-Marketing Agreement with EluciData to Break Down Barriers Faced by Metabolomics Researchers". Framingham, MA. 2019-06-21
MGI Tech Co., Ltd.. (6/20/19). "Press Release: MGI Forms Partnership with Karolinska Institutet Centre for Translational Microbiome Research (CTMR) to Understand the Effects of Microbiome on Human Health". Shenzhen. 2019-06-20
Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. 2019-06-20
Roche. (6/18/19). "Press Release: Japan Becomes the First Country to Approve Roche’s Personalised Medicine Rozlytrek". Basel. 2019-06-18
Debiopharm International SA. (6/12/19). "Press Release: Debiopharm and Ipsen Extend Their Strategic Decapeptyl (triptorelin) Partnership for another 15 Years". Lausanne & Paris. 2019-06-12
Celsius Therapeutics Inc.. (6/11/19). "Press Release: Celsius Therapeutics Appoints Tariq Kassum, M.D., as Chief Executive Officer". Cambridge, MA. 2019-06-11
Exscientia Ltd.. (6/11/19). "Press Release: Exscientia Expands International Collaborations with Shanghai-headquartered GT Apeiron Therapeutics". Oxford. 2019-06-11
Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore". 2019-06-10
Third Rock Ventures, LLC. (6/6/19). "Press Release: Third Rock Ventures Raises $770 Million Fund V". Boston, MA. 2019-06-06
Merck KGaA. (6/6/19). "Press Release: Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analysis Technology". Darmstadt. 2019-06-06
bioMérieux S.A.. (6/6/19). "Press Release: bioMérieux Increases Its Holding in Hybiome from 54% to 67%". Marcy l’Étoile. 2019-06-06
Biotage AB. (6/4/19). "Press Release: Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications". Uppsala. 2019-06-04
Agilent Technologies Inc.. (6/4/19). "Press Release: Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies". Santa Clara, CA. 2019-06-04
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top